Morgan Stanley Discloses 11.8% Stake in Orthofix Medical (OFIX)
Ticker: OFIX · Form: SC 13G · Filed: Feb 9, 2024 · CIK: 884624
Complexity: simple
Sentiment: bullish
Topics: institutional-ownership, SC-13G, investor-confidence
TL;DR
**Morgan Stanley just revealed an 11.8% stake in Orthofix (OFIX), signaling big institutional confidence.**
AI Summary
Morgan Stanley, a major financial institution, filed an SC 13G on February 9, 2024, disclosing its ownership of 2,476,700 shares of Orthofix Medical Inc. (OFIX) common stock as of December 31, 2023. This represents 11.8% of Orthofix's outstanding shares. This matters to investors because a significant stake by a large institutional investor like Morgan Stanley can signal confidence in the company's future, potentially influencing other investors and the stock price.
Why It Matters
This filing reveals a substantial institutional investment in Orthofix, which can be interpreted as a vote of confidence and may attract further investor interest.
Risk Assessment
Risk Level: low — This filing indicates a significant institutional investment, generally seen as a positive signal rather than a risk.
Analyst Insight
A smart investor would view this as a positive signal, potentially indicating institutional confidence in Orthofix Medical Inc. and might consider further research into OFIX's fundamentals and recent performance.
Key Numbers
- 2,476,700 — Shares Owned (Morgan Stanley's beneficial ownership in Orthofix Medical Inc.)
- 11.8% — Ownership Percentage (Morgan Stanley's stake in Orthofix Medical Inc. common stock)
Key Players & Entities
- Morgan Stanley (company) — the filer and institutional investor
- Orthofix Medical Inc. (company) — the subject company whose shares are being reported
- 2,476,700 shares (dollar_amount) — the total number of shares beneficially owned by Morgan Stanley
- 11.8% (dollar_amount) — the percentage of Orthofix Medical Inc.'s class of securities owned by Morgan Stanley
- December 31, 2023 (person) — the date of the event requiring the filing
- February 9, 2024 (person) — the filing date of the SC 13G
Forward-Looking Statements
- Orthofix Medical Inc. (OFIX) stock may experience increased investor interest due to Morgan Stanley's significant stake. (Orthofix Medical Inc.) — medium confidence, target: Q1 2024
FAQ
Who filed this SC 13G statement?
This SC 13G statement was filed by Morgan Stanley, a security broker, dealer, and flotation company, as indicated in the 'FILED BY' section of the filing.
What company's shares are the subject of this filing?
The subject company of this filing is Orthofix Medical Inc., identified by the CIK 0000884624 and the title 'Orthofix Medical Inc.' under the 'SUBJECT COMPANY' data.
How many shares of Orthofix Medical Inc. common stock does Morgan Stanley beneficially own?
Morgan Stanley beneficially owns 2,476,700 shares of Orthofix Medical Inc. common stock, as stated in the filing's cover page.
What percentage of Orthofix Medical Inc.'s common stock does Morgan Stanley's ownership represent?
Morgan Stanley's ownership represents 11.8% of Orthofix Medical Inc.'s common stock, as detailed in the filing's cover page.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified in the 'Date Of Event which Requires Filing of this Statement' section.
Filing Details
This Form SC 13G (Form SC 13G) was filed with the SEC on February 9, 2024 by December 31, 2023 regarding Orthofix Medical Inc. (OFIX).